Study phase II to determinate the efficacy of sunitinib in patients with renal cells carcinoma metastasic or locally avanced in patients not candidates to curative previous nefrectomy

Trial Profile

Study phase II to determinate the efficacy of sunitinib in patients with renal cells carcinoma metastasic or locally avanced in patients not candidates to curative previous nefrectomy

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Renal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Mar 2010 Results of an analysis which aims to identify genetic markers of response and adverse effects of sunitinib were presented at ASCO 2010 Genitourinary Cancers Symposium.
    • 19 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top